Check out what we have done with our previous project and what the scope looks like for the future, as well as any latest developments.
Over a period of two years, the EPSRC funded RiHN brought together a multi-disciplinary network of academics stakeholder organisations, clinical groups and industry to provide a forum to define the challenges of realising Redistributed Manufacturing (RDM) in deployed medical care In doing so the RiHN delivered the following outcomes
The strength of this report is that it combines key stakeholder expertise from a range of diverse backgrounds, enabling a multi-disciplinary perspective of the future of RDM in deployed healthcare. In order to seize the opportunities presented by RDM, RiHN proposes a bold new agenda that incorporates a whole system’s view of future implementation pathways and wider transformation implications. We are keen to hear your thoughts.. The time to take action is now. Implementing the opportunities proffered by RDM will be key in ensuring the future transformation of deployed medical care.
At the end of our last project we created ‘The RiHN White Paper’ it is the first serious attempt to gather expertise and to explore applications in promising areas of healthcare that could benefit from RDM and covers early-stage user needs, challenges and priorities. The paper served as a foundation for discussing future technological roadmaps and engaging the wider community and stakeholders, as well as policy makers, in addressing the potential impact of RDM.
See below publications/reports from the RiHN Team:
Thurman-Newell, J.A., Harrison, R., Hourd, P., Petzing, J., Rafiq, Q.A., Medcalf, N. (2016) Cell micro-factories: Feasibility of a redistributed manufacturing model for cell based therapeutics. In: EurOMA 2016 (23rd International Annual Conference of the European Operations Management Association), 17-22 Jun 2016, Trondheim, Norway
Please see below a list of relevant external links for further information:
Click on the links below: